Veefin Solutions IPO vs Vilin Bio Med IPO

Comparison between Veefin Solutions IPO and Vilin Bio Med IPO.

IPO Details

Veefin Solutions IPO is a SME Fixed Price IPO proposed to list at BSE SME while Vilin Bio Med IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of Veefin Solutions IPO is up to ₹44.37 Cr whereas the issue size of the Vilin Bio Med IPO is up to ₹11.38 Cr. The final issue price of Veefin Solutions IPO is ₹82.00 per share and of Vilin Bio Med IPO is ₹30.00 per share.

 Veefin Solutions IPOVilin Bio Med IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹82.00 per share₹30.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size1600 shares4000 shares
Fresh Issue Size25,61,600 shares37,92,000 shares
Fresh Issue Size (Amount)up to ₹21.01 Crup to ₹11.38 Cr
OFS Issue Size28,49,600 shares0 shares
OFS Issue Size (Amount)up to ₹23.37 Crup to ₹0.00 Cr
Issue Size Total54,11,200 shares37,92,000 shares
Issue Size Total (Amount)up to ₹44.37 Crup to ₹11.38 Cr

IPO Timetable

Veefin Solutions IPO opens on Jun 22, 2023, while Vilin Bio Med IPO opens on Jun 16, 2023. The closing date of Veefin Solutions IPO and Vilin Bio Med IPO is Jun 26, 2023, and Jun 21, 2023, respectively.

 Veefin Solutions IPOVilin Bio Med IPO
Issue OpenJun 22, 2023Jun 16, 2023
Issue CloseJun 26, 2023Jun 21, 2023
Basis Of Allotment (Tentative)Jun 30, 2023Jun 26, 2023
Initiation of Refunds (Tentative)Jul 03, 2023Jun 27, 2023
Credit of Share (Tentative)Jul 04, 2023Jun 29, 2023
Listing date (Tentative)Jul 05, 2023Jun 30, 2023

Financials & KPIs

Veefin Solutions IPO P/E ratio is 41.41, as compared to Vilin Bio Med IPO P/E ratio of 24.59.

 Veefin Solutions IPOVilin Bio Med IPO
Financials

Company Financials (Restated Consolidated)

Period Ended31 Jan 202331 Mar 2022
Assets48.2216.08
Total Income12.626.55
Profit After Tax3.500.70
NET Worth42.939.25
Reserves and Surplus24.599.24
Total Borrowing0.513.46
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Dec 202231 Mar 202231 Mar 202131 Mar 2020
Assets16.8713.5613.8914.01
Total Income9.0311.2211.7216.82
Profit After Tax1.280.030.120.16
NET Worth8.687.407.367.24
Reserves and Surplus5.384.104.063.94
Total Borrowing6.185.305.524.53
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)56.26%91.45%
Promoter Shareholding (Post-Issue)39.84%64.52%
P/E Ratio41.4124.59
Market Cap₹173.74 Cr.₹41.85 Cr.
ROE13.4214.76
ROCE11.328.58
Debt/Equity0.010.71
EPS₹0.48₹0.10
RoNW7.571.15

Shares Offered

In the Veefin Solutions IPO Retail Individual Investors (RII) are offered 27,05,600 shares while in Vilin Bio Med IPO retail investors are offered 27,05,600 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Veefin Solutions IPO and in Vilin Bio Med IPO.

 Veefin Solutions IPOVilin Bio Med IPO
Anchor Investor Reservation0 shares
Market Maker Reservation2,88,000 shares2,08,000 shares
QIB0 shares
NII27,05,600 shares18,96,000 shares
RII27,05,600 shares18,96,000 shares
Employee0 shares
Total54,11,200 shares37,92,000 shares

Bids Received (Subscription)

Veefin Solutions IPO subscribed 2.45x in total, whereas Vilin Bio Med IPO subscribed 2.80x.

 Veefin Solutions IPOVilin Bio Med IPO
NII (times)3.26x1.28x
RII (times)1.65x4.31x
Total (times)2.45x2.80x

Compare with others

Compare: